Dana-Farber colon cancer patient Dan Head and Dr. Matt Yurgelun on Dan’s genetic predisposition to colon cancer and advancements in genetic testing and management of hereditary cancer syndromes

Dan Head knew he had a genetic predisposition to cancer after his father was diagnosed with colon cancer and was on a preventative path leading up to his diagnosis—thus catching the cancer at an earlier, more treatable phase. Dr. Matt Yurgelun, director of the Lynch Syndrome Center at Dana-Farber joins Dan and OMF to discuss hereditary predispositions to cancer and his research.